Beate Fossum

p21‐<i>ras</i>‐peptide‐specific T‐cell responses in a patient with colorectal cancer. CD4⁺ and CD8⁺ T cells recognize a peptide corresponding to a common mutation (13Gly → Asp)

Beate Fossum, Tobias Gedde‐Dahl, Jarle Breivik et al. · International Journal of Cancer · 1994 · 86 citations

Life Sciences, Immunology, Oncology +17

CD8+T cells from a patient with colon carcinoma, specific for a mutant p21-Ras-derived peptide (GLY13?ASP), are cytotoxic towards a carcinoma cell line harbouring the same mutation

Beate Fossum, Anna Catharina Olsen, Erik Thorsby et al. · Cancer Immunology Immunotherapy · 1995 · 60 citations · Full text

Medicine, Immunology, Oncology +17

Overlapping epitopes encompassing a point mutation (12 Gly → Arg) in p21 ras can be recognized by HLA‐DR, ‐DP and ‐DQ restricted T cells

Beate Fossum, Tobias Gedde‐Dahl, Torbjern Hansen et al. · European Journal of Immunology · 1993 · 59 citations

Life Sciences, Immunology, Oncology +17

T cell clones specific for p21 ras‐derived peptides: Characterization of their fine specificity and HLA restriction

Tobias Gedde‐Dahl, Beate Fossum, Jon Amund Eriksen et al. · European Journal of Immunology · 1993 · 56 citations

Life Sciences, Immunology, Molecular Biology +17

A K‐<i>ras</i> 13GLY → ASP mutation is recognized by HLA‐DQ7 restricted T cells in a patient with colorectal cancer. Modifying effect of DQ7 on established cancers harbouring this mutation?

Beate Fossum, Jarle Breivik, Gunn Iren Meling et al. · International Journal of Cancer · 1994 · 38 citations

Life Sciences, Immunology, Oncology +17